Table 1 List of molecular targeted antineoplastic drugs with pediatric indications.
From: Gap between pediatric and adult approvals of molecular targeted drugs
ATC | Active ingredient | Pediatric indication | ||
|---|---|---|---|---|
U.S | E.U | JP | ||
L01XC02 | Rituximab | N | N | Y |
L01XC05 | Gemtuzumab ozogamicin | Y | N | N |
L01XC11 | Ipilimumab | Y | Y | N |
L01XC12 | Brentuximab vedotin | N | N | Y |
L01XC16 | Dinutuximab | Y | Y | NA |
L01XC17 | Nivolumab | Y | N | N |
L01XC18 | Pembrolizumab | Y | N | N |
L01XC19 | Blinatumomab | Y | Y | Y |
L01XC31 | Avelumab | Y | N | N |
L01XE01 | Imatinib mesylate | Y | Y | N |
L01XE06 | Dasatinib | Y | Y | N |
L01XE08 | Nilotinib hydrochloride hydrate | Y | Y | Y |
L01XE10 | Everolimus | Y | Y | Y |
L01XE12 | Vandetanib | N | Y | N |
L01XE53 | Larotrectinib sulfate | Y | Y | NA |
L01XE56 | Entrectinib | Y | NA | Y |
L01XX14 | Tretinoin | Y | NA | Y |
L01XX27 | Arsenic trioxide | Y | N | Y |
L01XX67 | Tagraxofusp | Y | NA | NA |
